Dabur India Ltd Q1 FY26 Concall Decoded: Ayurveda’s Modern-Day Powerhouse
Opening Hook While tech startups chase flashy valuations, Dabur quietly flexes its Ayurvedic muscle — boasting over 8.5 million outlets across India and reaching 80% of households. FY25 sales hit ₹12,563 crore, with 26% from international markets. Why does this matter? Because Dabur’s blend of tradition and innovation keeps it not just surviving but thriving in FMCG’s cutthroat arena. Stick around—things get spicier two scrolls down.
At a Glance
FY25 Sales: ₹12,563 Cr — steady growth on strong domestic and international footing.
Profit After Tax: ₹1,768 Cr — solid earnings powering dividends.
Dividend Payout Ratio: 80.2% — generous to shareholders.
International Business Growth: 17.2% (constant currency) — global Ayurveda on the rise.
Manufacturing Footprint: 14 Indian + 8 international plants — truly global operations.
Management’s Key Commentary
“Dabur is a global leader in Ayurveda and natural healthcare.” Translation: The OG wellness brand still packs a punch.
“Strong 20-year CAGR of 12% revenue and 13% EBITDA.” Slow and steady makes the ₹ crore.
“Focus on innovation and premiumization to capture market share.” New product launches keep the portfolio fresh.
“Digital advertising now accounts for 45% of media spends.” Ayurveda goes digital and goes big.
“Distribution reach expanded to 8.4 million outlets, up 0.5 million in FY25.” More stores, more sales, more Dabur.
“Sustainability targets achieved ahead of schedule — coal use eliminated, water use cut 30%.” Good for business, great for the planet.
